Publicacións en colaboración con investigadores/as de New York University Langone Medical Center (7)

2022

  1. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

    Circulation, Vol. 146, Núm. 16, pp. 1196-1206

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

2020

  1. Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancers

    NMR in Biomedicine, Vol. 33, Núm. 1

  2. The role of mobile health technologies in allergy care: An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 2, pp. 259-272

2019

  1. Quantitative non-gaussian intravoxel incoherent motion diffusion-weighted imaging metrics and surgical pathology for stratifying tumor aggressiveness in papillary thyroid carcinomas

    Tomography, Vol. 5, Núm. 1, pp. 26-35

2014

  1. Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial

    JAMA - Journal of the American Medical Association, Vol. 312, Núm. 10, pp. 1006-1015

  2. Erratum: Effect of darapladib on major coronary events after an acute coronary syndrome: The SOLID-TIMI 52 randomized clinical trial (JAMA (2014) 312:10(1006-1015))

    JAMA - Journal of the American Medical Association